The World Market for Transdermal Drug DeliveryReport Details:Published:September 2012No. of Pages: 100Price: Single User License – US$2500Transdermal (and related transmucosal) drug delivery is a well-established accepted route ofadministration for therapeutically beneficial medicines. There is no potential limit for thetherapeutic area for development of transdermal systems. Some therapeutic areas stand out,including sex hormones and pain management, due to the successful combination of the individualdrug molecules and available product technologies. The potential benefits that may be achievedusing transdermal delivery include continuous, controlled release and absorption of medicationinto the body, avoiding presystemic metabolism that may occur following oral dosing, includingboth intestinal and hepatic first-pass metabolism, improving patient compliance by offering moreconvenient dosing regimens , such as once or twice weekly dosing, and the ability to quicklydiscontinue treatment by removal of the system.This report, World Markets for Transdermal Drug Delivery is a comprehensive look at thetransdermal/transmucosal drug delivery market is divided into two sections. The first sectionencompasses the pharmaceutical products that utilize the drug delivery technology. The secondsection encompasses drug delivery technology and the revenues earned from licensing thattechnology. Because drug delivery technology is an integral part of sales of pharmaceuticals anddrug delivery technology cannot exist without pharmaceuticals, revenues have been reported thatinclude pharmaceutical sales for products utilizing that technology.This market is divided into two segments:•Market Size and Forecast for Transdermal Drug Delivery•Market Size and Forecast for Transmucosal Drug Delivery•Market Breakout by Region (US, Europe, Japan, ROW)•Review of Products on the Market•Market Breakout by Disease Treated (Cardiovascular, Hormones, Pain Management, Smoking Cessation, Other)•Market Breakout by Technology Revenues and Pharmaceutical Component Revenues•Profiles of Companies in the MarketThe research conducted by Kalorama included comprehensive research of secondary sourcessuch as company literature, databases, investment reports, and medical and business journals.New technologies, market developments, and research and development trends and expenditures
were identified through patent and database searches, as well as via interviews with keypersonnel. Person-to-person and telephone interviews were the primary method of gatheringinformation. E-mail correspondence was also used in the interview process. Interviews with 18 keyindustry officials, trade association representatives, consultants, healthcare providers, andgovernment personnel were compiled to form the primary basis of information—particularlyrevenue and market share data—presented in this report.All market data pertain to the worldwide market at the manufacturers’ level and presented in U.S.dollars. The base year for data was 2012. Historical data are provided for 2010 through 2011, withforecast data provided for 2013 through 2017. Compound annual growth rates (CAGR) areprovided for the 2010-2012, 2012-2017, and 2010–2017 periods.The following companies are profiled in this report•3M Pharmaceuticals•Access Pharmaceuticals, Inc.•Acrux Limited•ALZA Corporation•Antares Pharma, Inc.•Apricus BioSciences•Aveva Drug Delivery Systems•Generex Biotechnology Corporation•Inovio Pharmaceuticals, Inc.•Labtec GmbH•Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)•NITTO DENKO CORPORATION•Noven Pharmaceuticals, Inc.•Pantec Biosolutions AG•Tapemark•TEVA Pharmaceutical Industries Ltd.•Zosano PharmaGet your copy of this report @http://www.reportsnreports.com/reports/195651-the-world-market-for-transdermal-drug-delivery.htmlMajor points covered in Table of Contents of this report includeTable Of ContentsCHAPTER ONE: EXECUTIVE SUMMARYMarket DriversMarket Size and GrowthTotal Transdermal/Transmucosal Drug Delivery MarketTransdermal/Transmucosal Drug Delivery Only MarketCompetitive and Market Analysis
CHAPTER TWO: INTRODUCTION AND OVERVIEWScope and MethodologyReasons for Transdermal/Transmucosal Drug Delivery SystemsPhases of Drug ActionTransdermal drug DeliveryHistory of Transdermal Drug DeliveryAdvantages of Transdermal Drug DeliveryDisadvantages of Transdermal Drug DeliveryTransdermal Patch (Passive) Drug DeliveryTransfersomesMedicated TattoosCrystal Reservoir TechnologyActive Transdermal Drug ApplicationsElectrotransport Drug DeliveryIontophoresisReverse IontophoresisSonophoresisPhotomechanical WavesTransmucosal Drug DeliveryBuccal Drug DeliveryVaginal Drug DeliveryCHAPTER THREE: TRENDS AND DEVELOPMENTSNovel Transdermal ApprovalsInnovations in Transdermal Drug DeliveryAdhesive Technology and IssuesAdhesive Market IssuesGeneric Transdermal Study Design GuidelinesBiotechnological IssuesDevelopments in Insulin DeliveryNew Developments in Hormone Drug DeliveryNew Mucosal/Buccal Delivery SystemsOther New Drug Delivery SystemsMicroneedle-Assisted Transdermal Drug DeliveryControlled Thermal Energy TechnologyNew Ultrasound TechnologyTransdermal Products in DevelopmentCHAPTER FOUR: MARKET SIZE AND GROWTHThe Total Transdermal/Transmucosal Drug Delivery MarketTransdermal/Transmucosal Delivery Technology Only Market
CHAPTER FIVE: COMPETITIVE ANALYSISCompetitive LandscapeEmerging ParticipantsMarket AnalysisCHAPTER SIX: COMPANY PROFILES3M PharmaceuticalsAccess Pharmaceuticals, Inc.Acrux LimitedALZA CorporationAntares Pharma, Inc.Apricus BioSciencesAveva Drug Delivery SystemsGenerex Biotechnology CorporationInovio Pharmaceuticals, Inc.Labtec GmbHLohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)NITTO DENKO CORPORATIONNoven Pharmaceuticals, Inc.Pantec Biosolutions AGTapemarkTEVA Pharmaceutical Industries Ltd.Zosano PharmaAPPENDIX: COMPANY DIRECTORYTable Of ExibitsCHAPTER TWO: INTRODUCTION AND OVERVIEWTable 2-2: Select Leading Transdermal Delivery-Based ProductsCHAPTER THREE: TRENDS AND DEVELOPMENTSTable 3-1: Selected Transdermal Products in DevelopmentCHAPTER FOUR: MARKET SIZE AND GROWTHTable 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology andPharmaceuticals 2010-2017Figure 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology andPharmaceuticals 2010-2017Table 4-2: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmusal DrugDelivery Systems by Type 2010–2017Figure 4-2: The Worldwide Market for Pharmaceuticals UtilizingTransdermal/Transmucosal DrugDelivery Systems Revenues by Type 2010–2017
Table 4-3: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal DrugDelivery Technologies Market Share by Type 2010-2017Figure 4-3: Transdermal Drug Delivery Market by Disease Treated (Cardiovascular, Hormones,Pain Management, Smoking Cessation, Other)Table 4-4: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems byRegion (United States, Europe, Japan, ROW) 2010–2017Table 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems byPharmaceutical and Drug Delivery Component 2010-2017Table 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery SystemsDistribution of Revenue by Pharmaceutical and Drug Delivery Component 2010-2017Figure 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery SystemsDistribution of Revenue by Pharmaceutical and Drug Delivery Component 2010-2017Figure 4-6: The Worldwide Market for Transdermal/Transmucosal Drug Delivery SystemsDistribution of Revenue by Pharmaceutical and Drug Delivery Component 2012Figure 4-7: The Worldwide Market for Transdermal/Transmucosal Drug Delivery SystemsDistribution of Revenue by Pharmaceutical and Drug Delivery Component 2017CHAPTER FIVE: COMPETITIVE ANALYSISTable 5-1: Leading Suppliers of Transdermal/Transmucosal Drug Delivery TechnologyContact: firstname.lastname@example.org for more information.